Improved outcomes for patients with multidrug-resistant tuberculosis

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G TurettB A Fazal

Abstract

We conducted a retrospective study of patients with culture-confirmed multidrug-resistant tuberculosis (MDR-TB) at Bronx-Lebanon Hospital Center (South Bronx, NY) to determine what factors affected clinical and microbiological responses and survival. For the 38 patients with MDR-TB, reporting of first-line drug susceptibilities was relatively rapid (median time, 30 days). Thirty-four patients (89%) were infected with human immunodeficiency virus (HIV), and initial and overall response rates were 59% and 50%, respectively; the median survival was 315 days; and 50% of these patients died of tuberculosis. Bivariate analysis revealed that the following factors had a positive impact on response and survival: receiving > or = 2 consecutive weeks of appropriate therapy with at least two drugs to which the isolate was susceptible in vitro; starting appropriate therapy within 4 weeks of the diagnosis; and having tuberculosis that was limited to the lungs. Multivariate analysis revealed that the only variable associated with response was receipt of appropriate therapy for > or = 2 consecutive weeks. In contrast to findings in the published literature, our results indicate the outcome of MDR-TB can be improved, particularly for severely i...Continue Reading

Citations

Mar 22, 2001·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·S SasanoS Nitta
Sep 24, 2008·Seminars in Respiratory and Critical Care Medicine·Carole D MitnickSonya S Shin
Jun 13, 1996·The New England Journal of Medicine·W R BishaiR E Chaisson
Feb 4, 1999·The New England Journal of Medicine·D V Havlir, P F Barnes
Jan 10, 2003·The New England Journal of Medicine·Carole MitnickPaul Farmer
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S LockmanJ Tappero
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B Nachega, Richard E Chaisson
Mar 17, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·S S ShinM C Becerra
Apr 10, 1999·AIDS·A L PozniakL P Ormerod
Apr 9, 2004·Current Opinion in Pulmonary Medicine·Francis DrobniewskiRichard Coker
Jan 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wing Wai Yew, Chi Chiu Leung
Aug 30, 2001·Journal of Clinical Microbiology·A KrüünerG Källenius
Feb 1, 1997·Journal of Clinical Pathology·F A Drobniewski, M D Yates
Feb 1, 1997·Genitourinary Medicine·R Coker
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·N W Schluger, W N Rom
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·M Flament-SaillourJ Grosset
Jan 27, 2004·American Journal of Respiratory and Critical Care Medicine·Edward D ChanMichael D Iseman
Oct 27, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic SocietyUNKNOWN Infectious Diseases Society of America
Nov 1, 2006·Emerging Infectious Diseases·Eva NathansonMario C Raviglione
Jan 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·F K MukindaH S Schaaf
Feb 14, 2004·Lancet·Joia S MukherjeeKwonjune J Seung
Aug 2, 2002·Expert Opinion on Investigational Drugs·Laurent S Kremer, Gurdyal S Besra
Dec 7, 2010·Journal of Microbiological Methods·Gemeda AbebeRobert Colebunders
Jan 20, 2004·Tropical Medicine & International Health : TM & IH·Richard J Coker
Dec 1, 1996·Infectious Disease Clinics of North America·S Segal-MaurerJ J Rahal
Aug 8, 2009·Respiratory Medicine·Suhail Ahmad, Eiman Mokaddas
Aug 31, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F DrobniewskiUNKNOWN Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
N SalomonD Mildvan
American Journal of Respiratory and Critical Care Medicine
M M ParkW N Rom
© 2021 Meta ULC. All rights reserved